期刊文献+

藏药雪莲联合糖皮质激素在放射性肺炎进展期的干预作用 被引量:3

Intervention of Progressive Stage of Radiation Pneumonia with Tibetan Medicine Flos Saussureae Plus Glucocorticoid
原文传递
导出
摘要 【目的】研究藏药雪莲联合糖皮质激素在放射性肺炎进展期的干预作用。【方法】选取65例接受食道癌放疗后的放射性肺炎患者,随机分为3组:西药组20例、联合组21例和藏药组24例。西药组给予口服泼尼松(剂量为1 mg/kg)治疗,联合组给予口服泼尼松(剂量为0.5 mg/kg)联合肌肉注射雪莲注射液(剂量为2 m L/d)治疗,藏药组给予肌肉注射雪莲注射液(剂量为4 m L/d)治疗,以上药物均持续应用6周。观察各组患者治疗前后胸部高分辨率CT(HRCT)评分、LCQ咳嗽评分、6 min步行试验、肺功能[肺活量(VC),肺总量(TLC),弥散功能(DLco)]、动脉血气分析[动脉氧分压(PO2)]等的变化情况。【结果】(1)治疗后,联合组HRCT评分、6 min步行试验、LCQ咳嗽评分的改善值均高于西药组和藏药组(P<0.05),而藏药组仅LCQ咳嗽评分中的心理、社会评分改善值及改善后总分高于西药组(P<0.05)。(2)治疗后,联合组及藏药组的肺功能及PO2改善值均高于西药组(P<0.05),且联合组肺功能中的DLco及PO2改善值也均高于藏药组(P<0.05)。【结论】雪莲注射液联合糖皮质激素对于进展期的放射性肺炎有较好的治疗作用;大剂量雪莲注射液对于进展期的放射性肺炎的症状及影像学改善也有一定的帮助。 Objective To study the therapeutic effect of Tibetan medicine Flos Saussureae combined with glucocorticoid for progressive stage of radiation pneumonia. Methods A total of 65 post-chemotherapy radiation pneumonia patients with esophageal carcinoma were randomized into western medicine group(20 cases),combined group(21 cases)and Flos Saussureae group(24 cases),which were treated with prednisone(1 mg/kg,orally),prednisone(0.5 mg/kg,orally)plus Flos Saussureae Injection(2 m L/d, by intramuscular injection),and Flos Saussureae Injection(4 m L/d,by intramuscular injection)respectively. The medication lasted for 6 weeks. Before and after treatment,we investigated the scores of chest high resolution CT(HRCT),Leicester Cough Questionnaire(LCQ)scores,6-minute walk distance,pulmonary function indexes of vital capacity(VC),total lung capacity(TLC)and diffusion function DLco,and arterial oxygen partial pressure(PO2). Results(1)The scores of HRCT,6-minute walk distance and LCQ scores of the combined group were improved as compared with those of western medicine group and Flos Saussureae group(P〈0.05). The improvement of psychological scores, social function scores and overall socres of LCQ in Flos Saussureae group was superior to that in western medicine group(P〈0.05).(2)After treatment, pulmonary function indexes and PO2 of the combined group and Flos Saussureae group were improved compared with those of western medicine group(P〈0.05),and the improvement of DLco and PO2 of the combined group was superior to that of Flos Saussureae group(P〈0.05). Conclusion Flos Saussureae Injection combined with glucocorticoid exerts certain therapeutic effect for progressive stage of radiation pneumonia, and large-dose Flos Saussureae Injection is beneficial to the improvement of symptoms and imaging features of the patients.
出处 《广州中医药大学学报》 CAS 2017年第2期185-188,共4页 Journal of Guangzhou University of Traditional Chinese Medicine
关键词 食道癌放疗后 放射性肺炎 进展期 雪莲注射液 泼尼松 post-chemotherapy for esophageal carcinoma radiation pneumonia progressive stage Flos Saussureae Injection glucocorticoid
  • 相关文献

参考文献6

二级参考文献18

  • 1张振明 ,许爱霞 ,雷晓燕 ,高湘 ,葛斌.雪莲花醇提物的抗脂质过氧化作用[J].解放军药学学报,2005,21(1):30-32. 被引量:4
  • 2连军,熊元君,朱虎虎,吕晓敏.雪莲注射液长期毒性实验研究[J].现代中西医结合杂志,2007,16(4):458-460. 被引量:7
  • 3Ulrike B,Christian P S.The role of transforming growth facto r-β in lung development and disease[J].Chest,2004,125:754-5. 被引量:1
  • 4国家药品监督管理局.中药新药研究的技术要求[Z].,1999.. 被引量:3
  • 5徐淑云.药理实验方法学[M].2版.北京:人民卫生出版社,1994:1433-1439 被引量:2
  • 6Raghu G.Collard HR. EganJ J. et al. An official ATS/ERS/JRS/ ALA T statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management[J]. AmJ Respir Crit Care Med , 2011.183 (6) : 788-824. 被引量:1
  • 7Oda K. Ishimoto H. Yatera K. et al. High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis[J]. Respir Res.2014.15:10. 被引量:1
  • 8A TS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. A TS statement: guidelines for the six-minute walk test[J]. AmJ Respir Crit Care Med , 2002.166 (1) : 111-117. 被引量:1
  • 9Chilosi M. Poletti V. Rossi A. The pathogenesis of COPO and IPF:Oistinct horns of the same devil?[J]. Respir Res.2012. 13(1):3-9. 被引量:1
  • 10Cottin V. Nunes H. Brillet PY. et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity[J]. Eur RespirJ .2005.26(4) :586-593. 被引量:1

共引文献14

同被引文献58

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部